Martingale Asset Management L P Rhythm Pharmaceuticals, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$21.17 - $32.61 $1.78 Million - $2.75 Million	-84,215 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$18.13 - $30.61 $1.47 Million - $2.48 Million	-80,864 Reduced 48.99%	84,215 $1.82 Million
Q2 2020 Aug 10, 2020	BUY	$14.41 - $25.35 $1.34 Million - $2.35 Million	92,707 Added 128.1%	165,079 $3.68 Million
Q1 2020 May 11, 2020	BUY	$13.16 - $22.9 $952,415 - $1.66 Million	72,372 New	72,372 $1.1 Million

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.